The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

A study from the University of Birmingham, UK, has indicated that the use of digoxin could lead to substantial cost savings for the National Health Service (NHS) when treating senior individuals with ...

Digoxin toxicity is a life-threatening condition. The most common symptoms are gastrointestinal and include nausea, vomiting, abdominal pain and diarrhea. The cardiac manifestations are concerning ...

Digoxin 0.05mg; per mL; lime-flavored; contains alcohol 10%. Renal dysfunction: reduce dose. Sinus node disease. Incomplete AV block. Accessory AV pathway (Wolff-Parkinson-White syndrome).

One of cancer’s deadliest tricks is its ability to spread to other organs. An existing cardiac drug has now been found to reduce the risk of metastasis by dissolving circulating clusters of breast ...

The team reported on the study results in Nature Medicine, in a paper titled, “Digoxin for reduction of circulating tumor cell cluster size in metastatic breast cancer: a proof-of-concept trial ...

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

Heart failure (HF) is the leading cause of hospitalization among older adults. Digoxin has been shown to reduce hospitalization due to worsening HF. However, at the commonly prescribed dose of 0. ...

Digoxin is used extensively in combination with other medications in the treatment of heart failure, and is often prescribed to patients with atrial fibrillation — a kind of irregular heartbeat ...

In a clinical study, the researchers administered the drug digoxin at a low and safe dosage for one week to nine patients with metastatic breast cancer. The result: the number of cells per cluster ...

Digoxin blocks these ion pumps and thus suppresses the ion exchange. The cells therefore absorb more calcium from the outside of the cell membrane. This weakens the cohesion of the cancer cells in ...

Digoxin, originally derived from the foxglove flower, blocks the sodium/potassium ATPase pump. The mechanism by which this decreases atrioventricular (AV) conduction is not clear, butperhaps it is ...